| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 3.67e-07 | 188 | 98 | 9 | GO:0005201 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 2.44e-05 | 12 | 98 | 3 | GO:0030023 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 3.02e-05 | 323 | 98 | 9 | GO:1901681 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 4.01e-05 | 14 | 98 | 3 | GO:0097493 | |
| GeneOntologyMolecularFunction | heparin binding | 4.50e-05 | 192 | 98 | 7 | GO:0008201 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 5.26e-05 | 268 | 98 | 8 | GO:0005539 | |
| GeneOntologyMolecularFunction | L-glutamate uniporter activity | 7.13e-05 | 3 | 98 | 2 | GO:0140788 | |
| GeneOntologyMolecularFunction | structural molecule activity | NID2 KRT81 KRT83 KRT86 EFEMP2 EVPL KRTAP16-1 MFAP2 FBN1 FBN2 HMCN1 LTBP1 DMBT1 FBN3 | 1.12e-04 | 891 | 98 | 14 | GO:0005198 |
| GeneOntologyMolecularFunction | membrane potential driven uniporter activity | 2.36e-04 | 5 | 98 | 2 | GO:0022810 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 8.15e-04 | 85 | 98 | 4 | GO:0019199 | |
| GeneOntologyMolecularFunction | pore-forming activity | 1.05e-03 | 10 | 98 | 2 | GO:0140911 | |
| GeneOntologyMolecularFunction | uniporter activity | 1.05e-03 | 10 | 98 | 2 | GO:0015292 | |
| GeneOntologyMolecularFunction | calcium ion binding | NID2 DLL4 EFEMP2 NELL1 FBN1 FBN2 SCUBE2 HMCN1 CCBE1 LTBP1 FBN3 | 1.11e-03 | 749 | 98 | 11 | GO:0005509 |
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 1.23e-03 | 43 | 98 | 3 | GO:0030280 | |
| GeneOntologyMolecularFunction | sodium:phosphate symporter activity | 1.52e-03 | 12 | 98 | 2 | GO:0005436 | |
| GeneOntologyMolecularFunction | histone H3K9 methyltransferase activity | 1.80e-03 | 13 | 98 | 2 | GO:0046974 | |
| GeneOntologyMolecularFunction | potassium:proton antiporter activity | 2.09e-03 | 14 | 98 | 2 | GO:0015386 | |
| GeneOntologyMolecularFunction | L-glutamate transmembrane transporter activity | 2.40e-03 | 15 | 98 | 2 | GO:0005313 | |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 3.90e-07 | 4 | 96 | 3 | GO:0035583 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in extracellular region | 5.38e-06 | 8 | 96 | 3 | GO:0071694 | |
| GeneOntologyBiologicalProcess | sequestering of extracellular ligand from receptor | 1.57e-05 | 11 | 96 | 3 | GO:0035581 | |
| GeneOntologyBiologicalProcess | defense response to bacterium | DEFB104A CXCL13 RNASE12 OAS1 EVPL MUC5B DEFB103A DEFA1 DEFA3 DMBT1 | 1.91e-05 | 405 | 96 | 10 | GO:0042742 |
| GeneOntologyBiologicalProcess | extracellular regulation of signal transduction | 2.70e-05 | 13 | 96 | 3 | GO:1900115 | |
| GeneOntologyBiologicalProcess | extracellular negative regulation of signal transduction | 2.70e-05 | 13 | 96 | 3 | GO:1900116 | |
| GeneOntologyBiologicalProcess | defense response to Gram-positive bacterium | 7.24e-05 | 150 | 96 | 6 | GO:0050830 | |
| GeneOntologyCellularComponent | microfibril | 1.52e-11 | 13 | 98 | 6 | GO:0001527 | |
| GeneOntologyCellularComponent | extracellular matrix | NID2 ADAMTS3 ADAMTS2 EFEMP2 MUC5B DEFA1 CCN6 CCN4 MFAP2 FBN1 FBN2 HMCN1 CCBE1 LTBP1 DMBT1 FBN3 | 6.41e-08 | 656 | 98 | 16 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | NID2 ADAMTS3 ADAMTS2 EFEMP2 MUC5B DEFA1 CCN6 CCN4 MFAP2 FBN1 FBN2 HMCN1 CCBE1 LTBP1 DMBT1 FBN3 | 6.68e-08 | 658 | 98 | 16 | GO:0030312 |
| GeneOntologyCellularComponent | keratin filament | 3.65e-07 | 97 | 98 | 7 | GO:0045095 | |
| GeneOntologyCellularComponent | intermediate filament | 1.16e-05 | 227 | 98 | 8 | GO:0005882 | |
| GeneOntologyCellularComponent | supramolecular fiber | KRTAP9-4 KRT81 KRT83 KRT86 EFEMP2 OBSL1 EVPL KRTAP16-1 MFAP2 FBN1 FBN2 SQSTM1 KRTAP9-2 KRTAP9-9 LTBP1 CKAP2 FBN3 | 3.15e-05 | 1179 | 98 | 17 | GO:0099512 |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 3.34e-05 | 263 | 98 | 8 | GO:0045111 | |
| GeneOntologyCellularComponent | supramolecular polymer | KRTAP9-4 KRT81 KRT83 KRT86 EFEMP2 OBSL1 EVPL KRTAP16-1 MFAP2 FBN1 FBN2 SQSTM1 KRTAP9-2 KRTAP9-9 LTBP1 CKAP2 FBN3 | 3.43e-05 | 1187 | 98 | 17 | GO:0099081 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | NID2 ADAMTS3 ADAMTS2 EFEMP2 DEFA1 MFAP2 FBN1 FBN2 HMCN1 LTBP1 DMBT1 | 3.84e-05 | 530 | 98 | 11 | GO:0062023 |
| GeneOntologyCellularComponent | Golgi lumen | 1.73e-03 | 109 | 98 | 4 | GO:0005796 | |
| HumanPheno | Perifollicular hyperkeratosis | 1.40e-06 | 4 | 37 | 3 | HP:0007468 | |
| HumanPheno | Abnormal perifollicular morphology | 6.95e-06 | 6 | 37 | 3 | HP:0031285 | |
| MousePheno | abnormal tendon collagen fibril morphology | 5.32e-06 | 7 | 76 | 3 | MP:0011643 | |
| MousePheno | abnormal tendon morphology | 2.27e-05 | 31 | 76 | 4 | MP:0005503 | |
| MousePheno | abnormal viscerocranium morphology | ZEB1 KRTAP9-4 ADAMTS2 PDGFRB MECOM OAS1 NELL1 FBN1 FBN2 KRTAP9-2 KRTAP9-9 LTBP1 | 7.85e-05 | 593 | 76 | 12 | MP:0005274 |
| MousePheno | abnormal cranium morphology | ZEB1 KRTAP9-4 ADAMTS3 ADAMTS2 PDGFRB MECOM OAS1 NELL1 NEK1 FBN1 FBN2 KRTAP9-2 KRTAP9-9 LTBP1 | 1.07e-04 | 813 | 76 | 14 | MP:0000438 |
| MousePheno | abnormal endocrine gland morphology | ZEB1 KRTAP9-4 ACD ADAMTS3 PDGFRB OAS1 PLPPR5 ACVR1B PRDM2 NELL1 SIDT2 FBN1 FBXO9 KRTAP9-2 DIP2C KRTAP9-9 RNF208 | 1.09e-04 | 1144 | 76 | 17 | MP:0013560 |
| MousePheno | abnormal craniofacial bone morphology | ZEB1 KRTAP9-4 ADAMTS3 ADAMTS2 PDGFRB MECOM OAS1 NELL1 NEK1 FBN1 FBN2 KRTAP9-2 KRTAP9-9 LTBP1 | 1.28e-04 | 827 | 76 | 14 | MP:0002116 |
| MousePheno | abnormal jaw morphology | ZEB1 KRTAP9-4 ADAMTS2 PDGFRB MECOM OAS1 FBN1 FBN2 KRTAP9-2 KRTAP9-9 LTBP1 | 1.29e-04 | 530 | 76 | 11 | MP:0000454 |
| MousePheno | abnormal distal visceral endoderm morphology | 1.74e-04 | 4 | 76 | 2 | MP:0010126 | |
| MousePheno | effusion | 1.75e-04 | 152 | 76 | 6 | MP:0021205 | |
| MousePheno | abnormal aorta morphology | 2.17e-04 | 225 | 76 | 7 | MP:0000272 | |
| MousePheno | abnormal ascending aorta morphology | 2.21e-04 | 22 | 76 | 3 | MP:0009867 | |
| MousePheno | small adrenal glands | 2.56e-04 | 57 | 76 | 4 | MP:0002768 | |
| MousePheno | absent lymphatic vessels | 2.89e-04 | 5 | 76 | 2 | MP:0010194 | |
| MousePheno | ascending aorta aneurysm | 2.89e-04 | 5 | 76 | 2 | MP:0010661 | |
| MousePheno | abnormal craniofacial morphology | ZEB1 KRTAP9-4 ACD ADAMTS3 ADAMTS2 PDGFRB MECOM OAS1 ZEB2 NELL1 NEK1 FBN1 FBN2 CCBE1 KRTAP9-2 UHRF1 KRTAP9-9 LTBP1 | 3.16e-04 | 1372 | 76 | 18 | MP:0000428 |
| MousePheno | craniofacial phenotype | ZEB1 KRTAP9-4 ACD ADAMTS3 ADAMTS2 PDGFRB MECOM OAS1 ZEB2 NELL1 NEK1 FBN1 FBN2 CCBE1 KRTAP9-2 UHRF1 KRTAP9-9 LTBP1 | 3.16e-04 | 1372 | 76 | 18 | MP:0005382 |
| MousePheno | abnormal cutaneous collagen fibril morphology | 4.11e-04 | 27 | 76 | 3 | MP:0008438 | |
| MousePheno | thoracic aorta aneurysm | 4.31e-04 | 6 | 76 | 2 | MP:0010658 | |
| Domain | Growth_fac_rcpt_ | NID2 DLL4 KRT83 EFEMP2 CCN6 CCN4 NELL1 FBN1 FBN2 SCUBE2 HMCN1 LTBP1 FBN3 EPHB1 | 5.91e-14 | 156 | 96 | 14 | IPR009030 |
| Domain | cEGF | 5.24e-13 | 26 | 96 | 8 | IPR026823 | |
| Domain | cEGF | 5.24e-13 | 26 | 96 | 8 | PF12662 | |
| Domain | ASX_HYDROXYL | NID2 DLL4 EFEMP2 NELL1 FBN1 FBN2 SCUBE2 HMCN1 CCBE1 LTBP1 FBN3 | 3.57e-12 | 100 | 96 | 11 | PS00010 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | NID2 DLL4 EFEMP2 NELL1 FBN1 FBN2 SCUBE2 HMCN1 CCBE1 LTBP1 FBN3 | 6.84e-12 | 106 | 96 | 11 | IPR000152 |
| Domain | EGF_CA | 2.04e-11 | 86 | 96 | 10 | PF07645 | |
| Domain | EGF_CA | NID2 DLL4 EFEMP2 NELL1 FBN1 FBN2 SCUBE2 HMCN1 CCBE1 LTBP1 FBN3 | 3.23e-11 | 122 | 96 | 11 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | NID2 DLL4 EFEMP2 NELL1 FBN1 FBN2 SCUBE2 HMCN1 CCBE1 LTBP1 FBN3 | 3.86e-11 | 124 | 96 | 11 | IPR001881 |
| Domain | EGF_Ca-bd_CS | 6.93e-11 | 97 | 96 | 10 | IPR018097 | |
| Domain | EGF_CA | 8.52e-11 | 99 | 96 | 10 | PS01187 | |
| Domain | EGF-like_CS | NID2 DLL4 EFEMP2 NELL1 FBN1 FBN2 SCUBE2 HMCN1 CCBE1 LTBP1 FBN3 EPHB1 | 9.51e-09 | 261 | 96 | 12 | IPR013032 |
| Domain | EGF_2 | NID2 DLL4 EFEMP2 NELL1 FBN1 FBN2 SCUBE2 HMCN1 CCBE1 LTBP1 FBN3 EPHB1 | 1.13e-08 | 265 | 96 | 12 | PS01186 |
| Domain | TB | 2.27e-08 | 7 | 96 | 4 | PF00683 | |
| Domain | EGF_3 | NID2 DLL4 EFEMP2 NELL1 FBN1 FBN2 SCUBE2 HMCN1 CCBE1 LTBP1 FBN3 | 3.41e-08 | 235 | 96 | 11 | PS50026 |
| Domain | EGF | NID2 DLL4 EFEMP2 NELL1 FBN1 FBN2 SCUBE2 HMCN1 CCBE1 LTBP1 FBN3 | 3.41e-08 | 235 | 96 | 11 | SM00181 |
| Domain | - | 4.52e-08 | 8 | 96 | 4 | 3.90.290.10 | |
| Domain | EGF-like_dom | NID2 DLL4 EFEMP2 NELL1 FBN1 FBN2 SCUBE2 HMCN1 CCBE1 LTBP1 FBN3 | 6.16e-08 | 249 | 96 | 11 | IPR000742 |
| Domain | TB | 8.10e-08 | 9 | 96 | 4 | PS51364 | |
| Domain | TB_dom | 8.10e-08 | 9 | 96 | 4 | IPR017878 | |
| Domain | FBN | 1.32e-07 | 3 | 96 | 3 | IPR011398 | |
| Domain | EGF_1 | 7.60e-07 | 255 | 96 | 10 | PS00022 | |
| Domain | TSP_1 | 1.79e-05 | 63 | 96 | 5 | PF00090 | |
| Domain | TSP1 | 2.09e-05 | 65 | 96 | 5 | SM00209 | |
| Domain | TSP1_rpt | 2.09e-05 | 65 | 96 | 5 | IPR000884 | |
| Domain | TSP1 | 2.09e-05 | 65 | 96 | 5 | PS50092 | |
| Domain | EGF_3 | 2.80e-05 | 12 | 96 | 3 | PF12947 | |
| Domain | EGF_dom | 2.80e-05 | 12 | 96 | 3 | IPR024731 | |
| Domain | Keratin_B2_2 | 4.70e-05 | 39 | 96 | 4 | PF13885 | |
| Domain | EGF | 4.72e-05 | 126 | 96 | 6 | PF00008 | |
| Domain | Glyco_hormone_CN | 5.73e-05 | 15 | 96 | 3 | IPR006208 | |
| Domain | Cys_knot | 5.73e-05 | 15 | 96 | 3 | PF00007 | |
| Domain | G2F | 7.82e-05 | 3 | 96 | 2 | SM00682 | |
| Domain | CTCK_1 | 1.02e-04 | 18 | 96 | 3 | PS01185 | |
| Domain | GFP | 1.56e-04 | 4 | 96 | 2 | IPR009017 | |
| Domain | G2F | 1.56e-04 | 4 | 96 | 2 | PF07474 | |
| Domain | G2_nidogen/fibulin_G2F | 1.56e-04 | 4 | 96 | 2 | IPR006605 | |
| Domain | NIDOGEN_G2 | 1.56e-04 | 4 | 96 | 2 | PS50993 | |
| Domain | CT | 1.89e-04 | 22 | 96 | 3 | SM00041 | |
| Domain | KAP | 2.25e-04 | 58 | 96 | 4 | IPR002494 | |
| Domain | Keratin_2_head | 2.46e-04 | 24 | 96 | 3 | IPR032444 | |
| Domain | Keratin_2_head | 2.46e-04 | 24 | 96 | 3 | PF16208 | |
| Domain | Defensin_propep | 2.59e-04 | 5 | 96 | 2 | PF00879 | |
| Domain | Alpha-defensin | 2.59e-04 | 5 | 96 | 2 | IPR006081 | |
| Domain | Defensin_1 | 2.59e-04 | 5 | 96 | 2 | PF00323 | |
| Domain | Alpha-defensin_pro | 2.59e-04 | 5 | 96 | 2 | IPR016327 | |
| Domain | DEFENSIN | 2.59e-04 | 5 | 96 | 2 | PS00269 | |
| Domain | Defensin_propep | 2.59e-04 | 5 | 96 | 2 | IPR002366 | |
| Domain | IGFBP_CNN | 2.59e-04 | 5 | 96 | 2 | IPR012395 | |
| Domain | Cys_knot_C | 2.79e-04 | 25 | 96 | 3 | IPR006207 | |
| Domain | CTCK_2 | 2.79e-04 | 25 | 96 | 3 | PS01225 | |
| Domain | Keratin_II | 3.14e-04 | 26 | 96 | 3 | IPR003054 | |
| Domain | VWC | 3.93e-04 | 28 | 96 | 3 | PF00093 | |
| Domain | Di19_Zn_binding_dom | 5.40e-04 | 7 | 96 | 2 | IPR008598 | |
| Domain | zf-Di19 | 5.40e-04 | 7 | 96 | 2 | PF05605 | |
| Domain | Defensin_beta/alpha | 7.17e-04 | 8 | 96 | 2 | IPR006080 | |
| Domain | DEFSN | 7.17e-04 | 8 | 96 | 2 | SM00048 | |
| Domain | VWFC_1 | 8.31e-04 | 36 | 96 | 3 | PS01208 | |
| Domain | VWC | 9.74e-04 | 38 | 96 | 3 | SM00214 | |
| Domain | VWFC_2 | 9.74e-04 | 38 | 96 | 3 | PS50184 | |
| Domain | Keratin_B2 | 1.13e-03 | 40 | 96 | 3 | PF01500 | |
| Domain | VWF_dom | 1.31e-03 | 42 | 96 | 3 | IPR001007 | |
| Domain | - | 1.40e-03 | 11 | 96 | 2 | 2.40.155.10 | |
| Domain | GFP-like | 1.40e-03 | 11 | 96 | 2 | IPR023413 | |
| Domain | Insulin_GF-bd_Cys-rich_CS | 1.40e-03 | 11 | 96 | 2 | IPR017891 | |
| Domain | IGFBP_N_1 | 1.67e-03 | 12 | 96 | 2 | PS00222 | |
| Domain | uDENN | 2.29e-03 | 14 | 96 | 2 | SM00800 | |
| Domain | uDENN | 2.63e-03 | 15 | 96 | 2 | PF03456 | |
| Domain | UDENN | 2.99e-03 | 16 | 96 | 2 | PS50946 | |
| Domain | DDENN | 2.99e-03 | 16 | 96 | 2 | PS50947 | |
| Domain | DENN | 2.99e-03 | 16 | 96 | 2 | SM00799 | |
| Domain | dDENN | 2.99e-03 | 16 | 96 | 2 | SM00801 | |
| Domain | DENN | 2.99e-03 | 16 | 96 | 2 | PF02141 | |
| Domain | dDENN_dom | 2.99e-03 | 16 | 96 | 2 | IPR005112 | |
| Domain | uDENN_dom | 2.99e-03 | 16 | 96 | 2 | IPR005113 | |
| Domain | dDENN | 2.99e-03 | 16 | 96 | 2 | PF03455 | |
| Domain | DENN | 2.99e-03 | 16 | 96 | 2 | PS50211 | |
| Domain | DENN_dom | 2.99e-03 | 16 | 96 | 2 | IPR001194 | |
| Domain | IB | 3.79e-03 | 18 | 96 | 2 | SM00121 | |
| Domain | Intermediate_filament_CS | 4.18e-03 | 63 | 96 | 3 | IPR018039 | |
| Domain | VWC_out | 4.22e-03 | 19 | 96 | 2 | SM00215 | |
| Domain | PLAC | 4.22e-03 | 19 | 96 | 2 | PS50900 | |
| Domain | PLAC | 4.22e-03 | 19 | 96 | 2 | IPR010909 | |
| Domain | IGFBP-like | 4.68e-03 | 20 | 96 | 2 | IPR000867 | |
| Domain | IGFBP | 4.68e-03 | 20 | 96 | 2 | PF00219 | |
| Domain | IGFBP_N_2 | 4.68e-03 | 20 | 96 | 2 | PS51323 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 4.43e-08 | 37 | 77 | 6 | M27134 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.30e-07 | 44 | 77 | 6 | M26969 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 7.65e-07 | 32 | 77 | 5 | MM14854 | |
| Pathway | REACTOME_KERATINIZATION | 1.79e-06 | 153 | 77 | 8 | MM15343 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 2.12e-06 | 39 | 77 | 5 | MM14601 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 9.54e-06 | 25 | 77 | 4 | M39713 | |
| Pathway | REACTOME_KERATINIZATION | 2.34e-05 | 217 | 77 | 8 | M27640 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 3.60e-05 | 300 | 77 | 9 | M610 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 7.99e-05 | 258 | 77 | 8 | MM14572 | |
| Pathway | REACTOME_DEFENSINS | 1.97e-04 | 53 | 77 | 4 | M557 | |
| Pathway | REACTOME_DEFENSINS | 6.31e-04 | 31 | 77 | 3 | MM14568 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 8.07e-04 | 8 | 77 | 2 | M47850 | |
| Pubmed | Structure and site of expression of a murine type II hair keratin. | 2.17e-08 | 3 | 98 | 3 | 1372089 | |
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 1712823 | ||
| Pubmed | Novel KRT83 and KRT86 mutations associated with monilethrix. | 2.17e-08 | 3 | 98 | 3 | 25557232 | |
| Pubmed | 8.66e-08 | 4 | 98 | 3 | 12429738 | ||
| Pubmed | Human eye development is characterized by coordinated expression of fibrillin isoforms. | 8.66e-08 | 4 | 98 | 3 | 25406291 | |
| Pubmed | Heparin/heparan sulfate controls fibrillin-1, -2 and -3 self-interactions in microfibril assembly. | 8.66e-08 | 4 | 98 | 3 | 25034023 | |
| Pubmed | 8.66e-08 | 4 | 98 | 3 | 15797458 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 1.68e-07 | 86 | 98 | 6 | 28327460 | |
| Pubmed | 2.16e-07 | 5 | 98 | 3 | 17255108 | ||
| Pubmed | 2.16e-07 | 5 | 98 | 3 | 34411563 | ||
| Pubmed | Development, composition, and structural arrangements of the ciliary zonule of the mouse. | 2.16e-07 | 5 | 98 | 3 | 23493297 | |
| Pubmed | 4.31e-07 | 6 | 98 | 3 | 19349279 | ||
| Pubmed | 4.31e-07 | 6 | 98 | 3 | 7873879 | ||
| Pubmed | 6.81e-07 | 175 | 98 | 7 | 28071719 | ||
| Pubmed | An ultra-high sulfur keratin gene is expressed specifically during hair growth. | 1.20e-06 | 8 | 98 | 3 | 2465353 | |
| Pubmed | ADAMTS18 Deficiency Leads to Pulmonary Hypoplasia and Bronchial Microfibril Accumulation. | 1.54e-06 | 30 | 98 | 4 | 32882513 | |
| Pubmed | 1.76e-06 | 31 | 98 | 4 | 25762570 | ||
| Pubmed | 1.80e-06 | 9 | 98 | 3 | 38844137 | ||
| Pubmed | 2.37e-06 | 75 | 98 | 5 | 20637190 | ||
| Pubmed | 3.64e-06 | 37 | 98 | 4 | 11279113 | ||
| Pubmed | Characterization of a 300 kbp region of human DNA containing the type II hair keratin gene domain. | 4.69e-06 | 12 | 98 | 3 | 10692104 | |
| Pubmed | 4.69e-06 | 12 | 98 | 3 | 26405179 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 12399449 | ||
| Pubmed | Neutrophil defensins enhance lung epithelial wound closure and mucin gene expression in vitro. | 7.86e-06 | 2 | 98 | 2 | 12871849 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 21851253 | ||
| Pubmed | Molecular cloning of a novel brain-type Na(+)-dependent inorganic phosphate cotransporter. | 7.86e-06 | 2 | 98 | 2 | 10820226 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 34876472 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 12429739 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 16837860 | ||
| Pubmed | ZEBs: Novel Players in Immune Cell Development and Function. | 7.86e-06 | 2 | 98 | 2 | 30956067 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 28416756 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 21435559 | ||
| Pubmed | Vesicular glutamate transporters VGLUT1 and VGLUT2 in the developing mouse barrel cortex. | 7.86e-06 | 2 | 98 | 2 | 17289331 | |
| Pubmed | New Evidence Supporting the Role of FBN1 in the Development of Adolescent Idiopathic Scoliosis. | 7.86e-06 | 2 | 98 | 2 | 30044367 | |
| Pubmed | Material and mechanical properties of bones deficient for fibrillin-1 or fibrillin-2 microfibrils. | 7.86e-06 | 2 | 98 | 2 | 21440062 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 15131124 | ||
| Pubmed | Vesicular glutamate transporters 1 and 2 target to functionally distinct synaptic release sites. | 7.86e-06 | 2 | 98 | 2 | 15118123 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 12609600 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 24306957 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 18181146 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 15208269 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 20375168 | ||
| Pubmed | Prognostic Significance of Zinc Finger E-Box-Binding Homeobox Family in Glioblastoma. | 7.86e-06 | 2 | 98 | 2 | 29476046 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 22213144 | ||
| Pubmed | Plasma human neutrophil proteins-1, -2, and -3 levels in patients with bladder cancer. | 7.86e-06 | 2 | 98 | 2 | 23011762 | |
| Pubmed | Functional conservation of zinc-finger homeodomain gene zfh1/SIP1 in Drosophila heart development. | 7.86e-06 | 2 | 98 | 2 | 16957952 | |
| Pubmed | Fibrillin-1 and fibrillin-2 in human embryonic and early fetal development. | 7.86e-06 | 2 | 98 | 2 | 12524050 | |
| Pubmed | Human Neutrophil Peptides 1-3--early markers in development of colorectal adenomas and carcinomas. | 7.86e-06 | 2 | 98 | 2 | 18957723 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 20880148 | ||
| Pubmed | Microfibril structure masks fibrillin-2 in postnatal tissues. | 7.86e-06 | 2 | 98 | 2 | 20404337 | |
| Pubmed | The N-Terminal Region of Fibrillin-1 Mediates a Bipartite Interaction with LTBP1. | 7.86e-06 | 2 | 98 | 2 | 28669633 | |
| Pubmed | A missense mutation in the type II hair keratin hHb3 is associated with monilethrix. | 7.86e-06 | 2 | 98 | 2 | 15744029 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 20195543 | ||
| Pubmed | Characterization of metabolic health in mouse models of fibrillin-1 perturbation. | 7.86e-06 | 2 | 98 | 2 | 26902431 | |
| Pubmed | Fibrillln mutations in Marfan syndrome and related phenotypes. | 7.86e-06 | 2 | 98 | 2 | 8791520 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 18028110 | ||
| Pubmed | The mesodermal and myogenic specification of hESCs depend on ZEB1 and are inhibited by ZEB2. | 7.86e-06 | 2 | 98 | 2 | 37819755 | |
| Pubmed | Salivary levels of HNP 1-3 are related to oral ulcer activity in Behçet's disease. | 7.86e-06 | 2 | 98 | 2 | 22861387 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 8120105 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 35419902 | ||
| Pubmed | Fibrillin genes map to regions of conserved mouse/human synteny on mouse chromosomes 2 and 18. | 7.86e-06 | 2 | 98 | 2 | 8307578 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 17531353 | ||
| Pubmed | Fibrillin assembly: dimer formation mediated by amino-terminal sequences. | 7.86e-06 | 2 | 98 | 2 | 10504303 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 20424487 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 15221638 | ||
| Pubmed | Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. | 7.86e-06 | 2 | 98 | 2 | 7744963 | |
| Pubmed | Defensins: antimicrobial and cytotoxic peptides of mammalian cells. | 7.86e-06 | 2 | 98 | 2 | 8476558 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 26408953 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 22892238 | ||
| Pubmed | Detection of colorectal disease by stool defensin assay: an exploratory study. | 7.86e-06 | 2 | 98 | 2 | 17531545 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 21800314 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 26705736 | ||
| Pubmed | Arg-Gly-Asp-containing domains of fibrillins-1 and -2 distinctly regulate lung fibroblast migration. | 7.86e-06 | 2 | 98 | 2 | 18006876 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 25082886 | ||
| Pubmed | Rare variants in FBN1 and FBN2 are associated with severe adolescent idiopathic scoliosis. | 7.86e-06 | 2 | 98 | 2 | 24833718 | |
| Pubmed | Expression of WISPs and of their novel alternative variants in human hepatocellular carcinoma cells. | 7.86e-06 | 2 | 98 | 2 | 15650268 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 20025777 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 20424117 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 29950924 | ||
| Pubmed | Increased levels of human neutrophil alpha-defensins in chronic venous leg ulcers. | 7.86e-06 | 2 | 98 | 2 | 18472248 | |
| Pubmed | Identification of a major microfibril-associated glycoprotein-1-binding domain in fibrillin-2. | 7.86e-06 | 2 | 98 | 2 | 15044481 | |
| Pubmed | Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization. | 7.86e-06 | 2 | 98 | 2 | 2006422 | |
| Pubmed | Localization of human neutrophil peptide (HNP) and its messenger RNA in neutrophil series. | 7.86e-06 | 2 | 98 | 2 | 8080882 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 21747944 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 24265020 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 20529844 | ||
| Pubmed | Immunohistochemical expression of fibrillin-1 and fibrillin-2 during tooth development. | 7.86e-06 | 2 | 98 | 2 | 25524144 | |
| Pubmed | Protein interaction studies of MAGP-1 with tropoelastin and fibrillin-1. | 7.86e-06 | 2 | 98 | 2 | 11481325 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 18155679 | ||
| Pubmed | The capsule sensitizes Streptococcus pneumoniae to alpha-defensins human neutrophil proteins 1 to 3. | 7.86e-06 | 2 | 98 | 2 | 18474654 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 9665406 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 19864642 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 23133647 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 37948583 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 21333105 | ||
| Pubmed | Increased levels of alpha-defensin (-1, -2 and -3) in type 1 diabetic patients with nephropathy. | 7.86e-06 | 2 | 98 | 2 | 18003664 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 21525039 | ||
| Pubmed | Impairment of VGLUT2 but not VGLUT1 signaling reduces neuropathy-induced hypersensitivity. | 7.86e-06 | 2 | 98 | 2 | 19171494 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 28133913 | ||
| Pubmed | Fibrillins 1 and 2 perform partially overlapping functions during aortic development. | 7.86e-06 | 2 | 98 | 2 | 16407178 | |
| Interaction | HOXA1 interactions | KRTAP9-4 KRT81 KRT83 EFEMP2 CCN4 NELL1 MFAP2 FBN1 KRTAP9-2 LTBP1 RNF208 | 9.30e-07 | 356 | 95 | 11 | int:HOXA1 |
| Interaction | ELN interactions | 1.01e-05 | 29 | 95 | 4 | int:ELN | |
| Interaction | MFAP2 interactions | 2.16e-05 | 12 | 95 | 3 | int:MFAP2 | |
| Cytoband | 12q13 | 1.70e-05 | 71 | 98 | 4 | 12q13 | |
| Cytoband | 17q12-q21 | 4.47e-05 | 32 | 98 | 3 | 17q12-q21 | |
| Cytoband | 8p23.1 | 3.44e-04 | 154 | 98 | 4 | 8p23.1 | |
| Cytoband | 17q21.2 | 4.65e-04 | 70 | 98 | 3 | 17q21.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 5.49e-04 | 473 | 98 | 6 | chr17q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p15 | 1.36e-03 | 564 | 98 | 6 | chr11p15 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | 1.63e-03 | 234 | 98 | 4 | chr8p23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 2.18e-03 | 423 | 98 | 5 | chr12q13 | |
| Cytoband | 3q25.1 | 2.28e-03 | 33 | 98 | 2 | 3q25.1 | |
| Cytoband | Xq25 | 3.50e-03 | 41 | 98 | 2 | Xq25 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq25 | 4.77e-03 | 48 | 98 | 2 | chrXq25 | |
| GeneFamily | Keratins, type II | 1.46e-04 | 27 | 69 | 3 | 609 | |
| GeneFamily | CYR61/CTGF/NOV matricellular proteins | 2.13e-04 | 6 | 69 | 2 | 1046 | |
| GeneFamily | Fibulins | 3.96e-04 | 8 | 69 | 2 | 556 | |
| GeneFamily | Keratin associated proteins | 7.99e-04 | 109 | 69 | 4 | 619 | |
| GeneFamily | Defensins, alpha | 9.24e-04 | 12 | 69 | 2 | 502 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.46e-03 | 15 | 69 | 2 | 529 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 1.88e-03 | 17 | 69 | 2 | 1197 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 2.35e-03 | 19 | 69 | 2 | 50 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 4.07e-03 | 25 | 69 | 2 | 504 | |
| GeneFamily | PHD finger proteins | 4.93e-03 | 90 | 69 | 3 | 88 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 7.44e-03 | 34 | 69 | 2 | 487 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | NID2 EFEMP2 CCN6 CCN4 NELL1 MFAP2 FBN1 FBN2 HMCN1 LTBP1 DMBT1 FBN3 | 7.86e-12 | 196 | 96 | 12 | M3008 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | NID2 EFEMP2 CCN6 CCN4 NELL1 MFAP2 FBN1 FBN2 HMCN1 LTBP1 DMBT1 | 1.19e-10 | 191 | 96 | 11 | MM17059 |
| Coexpression | NABA_CORE_MATRISOME | NID2 EFEMP2 CCN6 CCN4 NELL1 MFAP2 FBN1 FBN2 HMCN1 LTBP1 DMBT1 FBN3 | 4.00e-10 | 275 | 96 | 12 | M5884 |
| Coexpression | NABA_CORE_MATRISOME | NID2 EFEMP2 CCN6 CCN4 NELL1 MFAP2 FBN1 FBN2 HMCN1 LTBP1 DMBT1 | 4.60e-09 | 270 | 96 | 11 | MM17057 |
| Coexpression | NABA_MATRISOME | NID2 ADAMTS3 ADAMTS2 INHBC EFEMP2 CXCL13 MUC5B CCN6 CCN4 NELL1 MFAP2 FBN1 FBN2 SCUBE2 HMCN1 CCBE1 LTBP1 DMBT1 FBN3 | 5.00e-09 | 1026 | 96 | 19 | M5889 |
| Coexpression | NABA_MATRISOME | NID2 ADAMTS3 ADAMTS2 INHBC EFEMP2 CXCL13 MUC5B CCN6 CCN4 NELL1 MFAP2 FBN1 FBN2 SCUBE2 HMCN1 CCBE1 LTBP1 DMBT1 | 2.35e-08 | 1008 | 96 | 18 | MM17056 |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 5.96e-06 | 352 | 96 | 9 | M17471 | |
| Coexpression | ROVERSI_GLIOMA_LOH_REGIONS | 2.24e-05 | 45 | 96 | 4 | M6712 | |
| Coexpression | ZHONG_PFC_C3_ASTROCYTE | 9.31e-05 | 389 | 96 | 8 | M39102 | |
| Coexpression | GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_DN | 9.60e-05 | 200 | 96 | 6 | M5153 | |
| Coexpression | NOUZOVA_METHYLATED_IN_APL | 1.02e-04 | 66 | 96 | 4 | M16097 | |
| Coexpression | MARTINEZ_RB1_TARGETS_DN | KRTAP9-4 KRT81 KRT83 KRT86 RXYLT1 FBN2 KRTAP9-2 KRTAP9-9 LTBP1 HNRNPLL | 1.06e-04 | 630 | 96 | 10 | MM1038 |
| Coexpression | HOLLERN_SQUAMOUS_BREAST_TUMOR | 1.07e-04 | 204 | 96 | 6 | MM966 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | ADAMTS3 ADAMTS2 PDGFRB EFEMP2 ZEB2 CCN4 MFAP2 FBN1 FBN2 HMCN1 UHRF1 | 1.01e-07 | 310 | 92 | 11 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 2.89e-07 | 207 | 92 | 9 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | ADAMTS3 ADAMTS2 SZT2 PDGFRB OBSL1 DENND2B ZEB2 NELL1 MFAP2 FBN1 FBN2 HMCN1 DIP2C LTBP1 | 3.51e-06 | 740 | 92 | 14 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.45e-06 | 288 | 92 | 9 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k5 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | ADAMTS3 ADAMTS2 PDGFRB EFEMP2 OBSL1 PHF8 DENND2B ZEB2 CCN4 MFAP2 FBN1 FBN2 HMCN1 UHRF1 | 5.37e-06 | 768 | 92 | 14 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000 | DENND2A SZT2 PDGFRB OBSL1 RNASE12 PHF8 DENND2B ZEB2 NELL1 MFAP2 FBN1 FBN2 HMCN1 LTBP1 | 6.70e-06 | 783 | 92 | 14 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | ZEB1 ADAMTS3 ADAMTS2 PDGFRB OBSL1 PHF8 DENND2B ZEB2 CCN4 MFAP2 FBN1 HMCN1 UHRF1 CKAP2 | 7.74e-06 | 793 | 92 | 14 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | DENND2A ZEB1 ADAMTS3 ADAMTS2 PDGFRB OBSL1 DENND2B NELL1 MFAP2 FBN1 FBN2 DCAF12L1 HMCN1 CCBE1 | 8.19e-06 | 797 | 92 | 14 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 8.53e-06 | 168 | 92 | 7 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k4_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.12e-05 | 323 | 92 | 9 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000_k5 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.24e-05 | 327 | 92 | 9 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k4_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500 | DENND2A PDGFRB DENND2B ZEB2 MFAP2 FBN1 FBN2 HMCN1 UHRF1 LTBP1 | 1.34e-05 | 418 | 92 | 10 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.53e-05 | 336 | 92 | 9 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.57e-05 | 337 | 92 | 9 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.96e-05 | 191 | 92 | 7 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k4_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.99e-05 | 265 | 92 | 8 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#2_top-relative-expression-ranked_500 | 2.08e-05 | 129 | 92 | 6 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_500_k2 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 2.17e-05 | 130 | 92 | 6 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.31e-05 | 354 | 92 | 9 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | ADAMTS3 ADAMTS2 PDGFRB EFEMP2 OBSL1 PHF8 DENND2B ZEB2 MFAP2 FBN1 FBN2 HMCN1 UHRF1 | 2.81e-05 | 773 | 92 | 13 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500 | 2.88e-05 | 364 | 92 | 9 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | ZEB1 ADAMTS2 PDGFRB EFEMP2 DENND2B ZEB2 CCN4 MFAP2 FBN1 FBN2 HMCN1 CCBE1 CKAP2 | 2.96e-05 | 777 | 92 | 13 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 3.48e-05 | 373 | 92 | 9 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 4.18e-05 | 146 | 92 | 6 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_500 | 4.73e-05 | 388 | 92 | 9 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_500 | 6.05e-05 | 156 | 92 | 6 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_500 | 8.68e-05 | 420 | 92 | 9 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.03e-04 | 107 | 92 | 5 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k3_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500 | 1.58e-04 | 356 | 92 | 8 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | NID2 DENND2A KLF11 PDGFRB EFEMP2 PHF8 DENND2B ZEB2 CDAN1 SIDT2 FBN1 FBN2 SCUBE2 CCBE1 TMLHE LTBP1 FBN3 | 1.67e-04 | 1466 | 92 | 17 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 1.90e-04 | 122 | 92 | 5 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.98e-04 | 123 | 92 | 5 | gudmap_developingGonad_e16.5_epididymis_1000_k3 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_100 | 2.14e-04 | 27 | 92 | 3 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_100 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | DENND2A PDGFRB OBSL1 PHF8 DENND2B ZEB2 MFAP2 FBN1 FBN2 HMCN1 UHRF1 LTBP1 | 2.33e-04 | 827 | 92 | 12 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | ADAMTS3 SZT2 PDGFRB OBSL1 DENND2B ZEB2 MFAP2 FBN1 FBN2 HMCN1 UHRF1 LTBP1 | 2.44e-04 | 831 | 92 | 12 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_1000 | NID2 KLF11 ADAMTS3 ADAMTS2 PLPPR5 CCN4 FBN2 DCAF12L1 LTBP1 CKAP2 ARAP1 EPHB1 | 2.61e-04 | 837 | 92 | 12 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_1000 | DENND2A KLF11 PDGFRB OBSL1 DENND2B ZEB2 MFAP2 FBN1 HMCN1 CCBE1 UHRF1 LTBP1 | 3.26e-04 | 858 | 92 | 12 | gudmap_dev gonad_e11.5_F_GonMes_Sma_1000 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_1000 | ADAMTS3 PDGFRB CXCL13 ZMAT4 NELL1 MFAP2 FBN1 FBN2 FNDC10 HMCN1 LTBP1 | 3.29e-04 | 734 | 92 | 11 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_1000 |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Podocytes_2500_K0 | ABHD17A NID2 ADAMTS2 EFEMP2 VPS8 COMTD1 CCN4 NELL1 MFAP2 FBN1 CCBE1 SQSTM1 LTBP1 ARAP1 | 3.91e-04 | 1143 | 92 | 14 | gudmap_RNAseq_e15.5_Podocytes_2500_K0 |
| CoexpressionAtlas | kidney_adult_RenCorpuscGlomer_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.64e-04 | 148 | 92 | 5 | gudmap_kidney_adult_RenCorpuscGlomer_k4_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_500 | 5.02e-04 | 423 | 92 | 8 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_500 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | ADAMTS2 CCN4 MFAP2 NEK1 FBN1 FBN2 DCAF12L1 HMCN1 TMLHE SOCS5 ARAP1 | 6.16e-04 | 791 | 92 | 11 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#2_top-relative-expression-ranked_1000 | 6.61e-04 | 91 | 92 | 4 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k2_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 7.61e-04 | 165 | 92 | 5 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_200 | 7.82e-04 | 166 | 92 | 5 | gudmap_kidney_P3_CapMes_Crym_200 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#3_top-relative-expression-ranked_100 | 8.17e-04 | 10 | 92 | 2 | gudmap_developingGonad_e18.5_ovary_100_k3 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500 | 9.23e-04 | 357 | 92 | 7 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 9.42e-04 | 466 | 92 | 8 | GSM777050_500 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000 | 9.61e-04 | 261 | 92 | 6 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k4_1000 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#1_top-relative-expression-ranked_200 | 1.11e-03 | 47 | 92 | 3 | gudmap_kidney_P4_CapMesRenVes_Crym_k1_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 1.18e-03 | 182 | 92 | 5 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.24e-03 | 184 | 92 | 5 | gudmap_developingGonad_e14.5_ epididymis_1000_k2 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | NID2 DENND2A ZEB1 ADAMTS2 PDGFRB ZEB2 FBN1 HMCN1 CCBE1 LTBP1 | 2.16e-11 | 200 | 97 | 10 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.84e-10 | 191 | 97 | 9 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-Myofibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 3.84e-10 | 191 | 97 | 9 | aa43b472bc8362f79ae63f09f1ca764718bbf22c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.84e-10 | 191 | 97 | 9 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.02e-10 | 192 | 97 | 9 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.21e-10 | 193 | 97 | 9 | 59b8186d0221fba06a16157e9d148399ed801f38 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.21e-10 | 193 | 97 | 9 | dc92680b4bb9fc26430c92e03adb839c8c3b3b98 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.21e-10 | 193 | 97 | 9 | 03678162648bd5b1d65a5450b60c8863edbf95c7 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-4-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.77e-10 | 200 | 97 | 9 | 4dbe21cb63569f28c7017cda065ea5ee00d7254e | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.77e-10 | 200 | 97 | 9 | 8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-4|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 5.77e-10 | 200 | 97 | 9 | bde938e5a18844fb8cc1d1be5a086809f7e2b97d | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Myofibroblasts|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 5.77e-10 | 200 | 97 | 9 | ca777a7d001848f6d01c613ff2bda7e4f3e20521 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-4|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.77e-10 | 200 | 97 | 9 | 8256511b099c3eab8e33194f90c9ff354e7cfe8e | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.77e-10 | 200 | 97 | 9 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 5.77e-10 | 200 | 97 | 9 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.77e-10 | 200 | 97 | 9 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.42e-09 | 185 | 97 | 8 | 87c416d14ca6255bee39b16e7571553e36ee3069 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.74e-09 | 186 | 97 | 8 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.53e-09 | 191 | 97 | 8 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.53e-09 | 191 | 97 | 8 | 053b3664f509baa107feaf90730f80ebf9ac8f14 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.53e-09 | 191 | 97 | 8 | 0fae1c2ef9f83ac7721d0a9d69455bf97eed9257 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.93e-09 | 192 | 97 | 8 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.93e-09 | 192 | 97 | 8 | 38d7a24ae205ef91ed2e0f402d8022f2a9cdb243 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.93e-09 | 192 | 97 | 8 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.93e-09 | 192 | 97 | 8 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.93e-09 | 192 | 97 | 8 | 04d155897ed075c359933080e36a4ab2150b6e9f | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.93e-09 | 192 | 97 | 8 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.93e-09 | 192 | 97 | 8 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.93e-09 | 192 | 97 | 8 | 84149a5c6c3b3c9b86aed77cf8e72d99ef099fab | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-08 | 193 | 97 | 8 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 1.08e-08 | 194 | 97 | 8 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-08 | 195 | 97 | 8 | edd4cd8402af81737b2074f9dce71cc6ab09be7e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-08 | 195 | 97 | 8 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-08 | 196 | 97 | 8 | b8759e6231e0254797d6c30930407b79440c57bb | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-08 | 196 | 97 | 8 | ba869f7a86f37fd6d84d6ad69baca0e0faaf5887 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-08 | 196 | 97 | 8 | 30ad56d49000e4ddce73b4443b3994564bd1e2d6 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.17e-08 | 196 | 97 | 8 | 275e153347caf94edc0c50021bbab49c8696fecb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-08 | 197 | 97 | 8 | ae0435f4b4a9cdedb1c201fc56921048390097bf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-08 | 197 | 97 | 8 | 37f6b6f2809b952382eaebb642b0aad6371f4251 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-08 | 197 | 97 | 8 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_4_(MMP1+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.26e-08 | 198 | 97 | 8 | 229588189825b1080181db9515185677b742c668 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|kidney / Disease (COVID-19 only), tissue and cell type | 1.26e-08 | 198 | 97 | 8 | ca26ca460856b1faaa3e83766da6abdf63af2b51 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.26e-08 | 198 | 97 | 8 | a699b365d3b6149f13f02b2e2ae9b6fdce761848 | |
| ToppCell | Fibroblasts-HLA-DRA_high_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.26e-08 | 198 | 97 | 8 | e8c0fbf306fae13e97caa294d7c99a564bd97130 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.31e-08 | 199 | 97 | 8 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.31e-08 | 199 | 97 | 8 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.31e-08 | 199 | 97 | 8 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 1.31e-08 | 199 | 97 | 8 | 211c3a08f2d484ab7a3368006767289088f0d957 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.31e-08 | 199 | 97 | 8 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.31e-08 | 199 | 97 | 8 | 21335475bbfbad8a6943b8076a6c1c67f3eec5d3 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.31e-08 | 199 | 97 | 8 | e78f661b40da34768469549b6e755d330be6bbd8 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts|LPS_only / Treatment groups by lineage, cell group, cell type | 1.31e-08 | 199 | 97 | 8 | 1a0add79f4e34078b3475eb11c85a4234bda197c | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 1.31e-08 | 199 | 97 | 8 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Myofibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.36e-08 | 200 | 97 | 8 | e504570fd7eec1524c401b1cfa9d10822d80d994 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.36e-08 | 200 | 97 | 8 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.36e-08 | 200 | 97 | 8 | 4f7e26b27bd51c32420ed8c2f52d070aee542159 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.36e-08 | 200 | 97 | 8 | 6e3d1ae0ef84d3075afa40129a41169996462672 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.36e-08 | 200 | 97 | 8 | 3dacd0afe69bc16bb33336ea9ea99a9cd47731d9 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.36e-08 | 200 | 97 | 8 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.36e-08 | 200 | 97 | 8 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.36e-08 | 200 | 97 | 8 | 54806080b5e97859ee6a4a9b4f19e22021c218f5 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell|Adult / Lineage, Cell type, age group and donor | 8.30e-08 | 167 | 97 | 7 | d584a8548a5317bd9686b3be8246ae6ed568796b | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.49e-07 | 182 | 97 | 7 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 1.61e-07 | 184 | 97 | 7 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-07 | 184 | 97 | 7 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.67e-07 | 185 | 97 | 7 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.67e-07 | 185 | 97 | 7 | 1ac6a32cc56d5d819649bdd99518e2ead0eead4c | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-07 | 185 | 97 | 7 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-07 | 185 | 97 | 7 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | (0)_MSCs|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.73e-07 | 186 | 97 | 7 | a832c1e0035bcd559722eccf262c145deb3494c7 | |
| ToppCell | (0)_MSCs-(00)_Lepr-MSC|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.73e-07 | 186 | 97 | 7 | f0d156167d7cc2cd8a76e5a364233e9f2170bc01 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 1.79e-07 | 187 | 97 | 7 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-07 | 189 | 97 | 7 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-07 | 189 | 97 | 7 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-07 | 189 | 97 | 7 | bba28f57a0708515fdd5acd9592dbbe4a4f57116 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.93e-07 | 189 | 97 | 7 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.93e-07 | 189 | 97 | 7 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-07 | 189 | 97 | 7 | cf293b23a4c0e8a0c9f09115b1d53d9b11de72e2 | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-07 | 189 | 97 | 7 | 87323e86a5b5d159920a07e6bd7ef5e3438cd085 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.93e-07 | 189 | 97 | 7 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-07 | 189 | 97 | 7 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-07 | 190 | 97 | 7 | 2e592323085ba9c019d678ac2a784462ab470ed9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-07 | 190 | 97 | 7 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-07 | 190 | 97 | 7 | 445952b70abffadb6ccc1ed4bbf61a88b06b73b3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-07 | 191 | 97 | 7 | a6c57627077fa980b7ec1d3894b5f31bfb11b738 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.07e-07 | 191 | 97 | 7 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-07 | 191 | 97 | 7 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-07 | 191 | 97 | 7 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-07 | 191 | 97 | 7 | 7b0d42a877540dbb346a76a62403e0d5d3e07fa6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-07 | 191 | 97 | 7 | 8f6d592edc32fdb901af30501d4360512334e8c2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-07 | 191 | 97 | 7 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-07 | 191 | 97 | 7 | cd854b9c426924fdc84bf7f411f6dea447143e79 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.15e-07 | 192 | 97 | 7 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-07 | 192 | 97 | 7 | bc84b9ce01b4d826a682842ab8a395dac9b91183 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-07 | 192 | 97 | 7 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | (0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|(0)_Normal/No_Treatment / Stress and Cell class | 2.15e-07 | 192 | 97 | 7 | 7a2ad0bdae647b88e799e62767605f2f3c5a426f | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.15e-07 | 192 | 97 | 7 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.15e-07 | 192 | 97 | 7 | b9e4585bea280ca0ae159f0c6a2bf7b88a15a6e6 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-07 | 192 | 97 | 7 | 9333aba0d04203ccccad78d82bf6359922f810a7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-07 | 192 | 97 | 7 | 0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1 | |
| Drug | flufenacet | 1.53e-06 | 6 | 98 | 3 | CID000086429 | |
| Drug | desmosine | 3.25e-06 | 53 | 98 | 5 | CID000025435 | |
| Drug | 1xqc | 1.24e-05 | 11 | 98 | 3 | CID005287617 | |
| Drug | 2-methoxyethoxy)acetic acid | 1.83e-05 | 2 | 98 | 2 | CID000027642 | |
| Drug | p-sulfobenzyl alcohol | 1.83e-05 | 2 | 98 | 2 | CID000441138 | |
| Drug | tebuquine | 1.83e-05 | 2 | 98 | 2 | CID000071991 | |
| Drug | 3,5-di-O-galloylquinic acid | 1.83e-05 | 2 | 98 | 2 | CID000460896 | |
| Drug | melicopicine | 1.83e-05 | 2 | 98 | 2 | CID000101253 | |
| Drug | 1,2,5,6-tetramethylnaphthalene | 1.83e-05 | 2 | 98 | 2 | CID006427081 | |
| Drug | 1,4,5-trimethylnaphthalene | 1.83e-05 | 2 | 98 | 2 | CID000016478 | |
| Drug | Chrysin [480-40-0]; Up 200; 15.8uM; HL60; HT_HG-U133A | 2.25e-05 | 196 | 98 | 7 | 3106_UP | |
| Drug | Pentetic acid [67-43-6]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 2.25e-05 | 196 | 98 | 7 | 5629_UP | |
| Drug | Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Up 200; 17.8uM; MCF7; HT_HG-U133A | 2.32e-05 | 197 | 98 | 7 | 5276_UP | |
| Drug | Androsterone [53-41-8]; Up 200; 13.8uM; PC3; HT_HG-U133A | 2.32e-05 | 197 | 98 | 7 | 4635_UP | |
| Drug | Azathioprine [446-86-6]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 2.32e-05 | 197 | 98 | 7 | 5262_UP | |
| Drug | LGD2226 | 4.58e-05 | 46 | 98 | 4 | CID011560224 | |
| Drug | 4-ethylbenzoate | 5.49e-05 | 3 | 98 | 2 | CID000012086 | |
| Drug | sulfonamide-3 | 5.49e-05 | 3 | 98 | 2 | CID009847197 | |
| Drug | ATBI | 6.02e-05 | 18 | 98 | 3 | CID000505862 | |
| Drug | TAAD | 9.72e-05 | 21 | 98 | 3 | CID000133445 | |
| Drug | lactucin | 1.09e-04 | 4 | 98 | 2 | CID000442266 | |
| Drug | Lactupicrin | 1.09e-04 | 4 | 98 | 2 | CID000174880 | |
| Drug | topanol A | 1.09e-04 | 4 | 98 | 2 | CID000015884 | |
| Drug | 4-fluorobenzoyl chloride | 1.09e-04 | 4 | 98 | 2 | CID000067879 | |
| Drug | xenognosin B | 1.09e-04 | 4 | 98 | 2 | CID005280551 | |
| Drug | AC1L3OZP | 1.09e-04 | 4 | 98 | 2 | CID000092862 | |
| Drug | sperabillin A | 1.09e-04 | 4 | 98 | 2 | CID006441177 | |
| Disease | Beaded hair | 2.39e-08 | 3 | 86 | 3 | cv:C0546966 | |
| Disease | connective tissue disease (implicated_via_orthology) | 2.39e-08 | 3 | 86 | 3 | DOID:65 (implicated_via_orthology) | |
| Disease | MONILETHRIX | 2.39e-08 | 3 | 86 | 3 | 158000 | |
| Disease | monilethrix (is_implicated_in) | 2.39e-08 | 3 | 86 | 3 | DOID:0050472 (is_implicated_in) | |
| Disease | Monilethrix | 9.54e-08 | 4 | 86 | 3 | C0546966 | |
| Disease | depressive symptom measurement, response to antidepressant | 6.06e-06 | 88 | 86 | 5 | EFO_0007006, GO_0036276 | |
| Disease | hair disease (is_implicated_in) | 8.40e-06 | 2 | 86 | 2 | DOID:421 (is_implicated_in) | |
| Disease | Hennekam syndrome (is_implicated_in) | 2.51e-05 | 3 | 86 | 2 | DOID:0060366 (is_implicated_in) | |
| Disease | Hennekam lymphangiectasia-lymphedema syndrome | 2.51e-05 | 3 | 86 | 2 | C0340834 | |
| Disease | aortic aneurysm (is_implicated_in) | 2.51e-05 | 3 | 86 | 2 | DOID:3627 (is_implicated_in) | |
| Disease | scoliosis (is_implicated_in) | 5.02e-05 | 4 | 86 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | Osteoarthritis, Knee | 5.02e-05 | 4 | 86 | 2 | C0409959 | |
| Disease | FEV/FEC ratio | ABHD17A NID2 ADAMTS2 MECOM ACVR1B DENND2B ZEB2 MFAP2 FBN1 HMCN1 LTBP1 DMBT1 ARAP1 | 5.45e-05 | 1228 | 86 | 13 | EFO_0004713 |
| Disease | aortic dissection (is_marker_for) | 2.32e-04 | 8 | 86 | 2 | DOID:0080685 (is_marker_for) | |
| Disease | Osteitis Deformans | 2.98e-04 | 9 | 86 | 2 | C0029401 | |
| Disease | glycerophospholipid measurement | 4.00e-04 | 49 | 86 | 3 | EFO_0007630 | |
| Disease | Liver Cirrhosis, Experimental | 4.26e-04 | 774 | 86 | 9 | C0023893 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 5.04e-04 | 53 | 86 | 3 | C4707243 | |
| Disease | Heschl's gyrus morphology measurement | 5.04e-04 | 53 | 86 | 3 | EFO_0005852 | |
| Disease | rheumatic heart disease (biomarker_via_orthology) | 5.44e-04 | 12 | 86 | 2 | DOID:0050827 (biomarker_via_orthology) | |
| Disease | Familial Nonmedullary Thyroid Cancer | 7.61e-04 | 61 | 86 | 3 | C3501844 | |
| Disease | Nonmedullary Thyroid Carcinoma | 7.61e-04 | 61 | 86 | 3 | C3501843 | |
| Disease | ascending aortic diameter | 7.63e-04 | 140 | 86 | 4 | EFO_0021787 | |
| Disease | severe aplastic anemia | 8.60e-04 | 15 | 86 | 2 | EFO_0006927 | |
| Disease | Malignant neoplasm of breast | 1.13e-03 | 1074 | 86 | 10 | C0006142 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 1.17e-03 | 157 | 86 | 4 | DOID:224 (biomarker_via_orthology) | |
| Disease | Disease Exacerbation | 1.40e-03 | 165 | 86 | 4 | C0235874 | |
| Disease | Disproportionate short stature | 1.50e-03 | 77 | 86 | 3 | C0878659 | |
| Disease | unipolar depression, bipolar disorder, schizophrenia | 1.54e-03 | 20 | 86 | 2 | EFO_0003761, MONDO_0004985, MONDO_0005090 | |
| Disease | glomerulonephritis (biomarker_via_orthology) | 1.54e-03 | 20 | 86 | 2 | DOID:2921 (biomarker_via_orthology) | |
| Disease | monocyte count | SZT2 PDGFRB INHBC EFEMP2 RNASE12 MECOM DENND2B DEFA3 SQSTM1 MED12L HNRNPLL | 1.55e-03 | 1320 | 86 | 11 | EFO_0005091 |
| Disease | Papillary thyroid carcinoma | 2.05e-03 | 86 | 86 | 3 | C0238463 | |
| Disease | Neoplasm Invasiveness | 2.09e-03 | 184 | 86 | 4 | C0027626 | |
| Disease | dental caries | 2.21e-03 | 187 | 86 | 4 | EFO_0003819 | |
| Disease | glioblastoma (is_implicated_in) | 2.22e-03 | 24 | 86 | 2 | DOID:3068 (is_implicated_in) | |
| Disease | coronary artery disease | ZEB1 ADAMTS3 INHBC RNASE12 MECOM DENND2B ZEB2 NELL1 FBN2 UHRF1 | 2.47e-03 | 1194 | 86 | 10 | EFO_0001645 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RRVLTYGCCSEPYPD | 211 | Q9GZZ6 | |
| RYYRLLQSPLCAGCS | 211 | Q9UJX6 | |
| IYCSDTALYCPEERR | 226 | Q9BUH8 | |
| CYTDYCNRIDLRVPS | 96 | P36896 | |
| SYSLYGICREACQVP | 401 | P18825 | |
| RSYTCTCRPGYTGVD | 306 | Q9NR61 | |
| YYCSLRGIPRQCIPE | 4821 | Q86UQ4 | |
| CMYVRCVPGARYTVL | 101 | Q96GS6 | |
| CDYSGDRPRYAIGVC | 101 | O95388 | |
| INIPGSYRCKCTRGY | 1781 | Q75N90 | |
| GSYLCTCPAGYTLRE | 2186 | Q75N90 | |
| RLPEVYCVISRLGCF | 791 | P78524 | |
| YGIRSEYCIRKIICP | 1956 | Q12830 | |
| YTCCPYIGELRKLLA | 796 | Q8IWY9 | |
| CRMEVLSRYCSIPGY | 1071 | O95450 | |
| VCRPNAALCRVYYEA | 666 | Q8WWK9 | |
| YAYVVDACQPTCRGL | 701 | Q9HC84 | |
| YAGCCTLKIEYARPT | 231 | Q8WVV9 | |
| RYTCRYCGKIFPRSA | 911 | Q03112 | |
| CVPSEGDYRFRICTV | 581 | O75147 | |
| EASPICTCRTGYYRA | 296 | P54762 | |
| SRRVCICLATFPYVY | 136 | Q96RB7 | |
| CSSPERCILAYLYDL | 921 | Q86YW9 | |
| RTCIGTPYYLSPEIC | 161 | Q96PY6 | |
| RCQYVVTCAGLYSDR | 251 | Q9H9P8 | |
| LPCDSYREGYSACVA | 81 | Q9Y543 | |
| CCVPTARRPLSLLYY | 316 | P55103 | |
| CITAAPYRGISCYRG | 26 | O43790 | |
| IRLPYCRENVCLTYC | 301 | Q5VW00 | |
| TGDCCYINPLVRRTV | 106 | Q32ZL2 | |
| NLPVRYTCICYEGYR | 891 | Q14766 | |
| EGYRCYRSASPTVPR | 2016 | Q92817 | |
| LKERCFRGSSYPVCV | 41 | P00973 | |
| QGVLEVYYTSLRCRC | 21 | O43927 | |
| GLYRCDCVPGYIRVD | 456 | Q92832 | |
| ECFILSGYRRLPCTA | 56 | Q6ZVX9 | |
| NTRGSYRCVCPRGYR | 5291 | Q96RW7 | |
| LPGSYRCECRSGYEF | 821 | Q14112 | |
| RPRYETGVCAYLVAV | 106 | O95389 | |
| SYKDPYSICVRGECV | 671 | O15072 | |
| CYCRIPACIAGERRY | 66 | P59665 | |
| PACIAGERRYGTCIY | 71 | P59665 | |
| CYCRIPACIAGERRY | 66 | P59666 | |
| PACIAGERRYGTCIY | 71 | P59666 | |
| LPEVYCIVSRLGCFS | 661 | Q9ULE3 | |
| LSLVCRGFYICARDP | 216 | Q9UK97 | |
| TRCIDVRPGYCYTAL | 326 | P35555 | |
| VRPGYCYTALTNGRC | 331 | P35555 | |
| CRCPTGYYLNEDTRV | 1631 | P35555 | |
| YTRFPCERVLLGASC | 116 | F2Z333 | |
| GRGSPCIQCRYDSYR | 741 | Q8ND61 | |
| INTLGSYRCECREGY | 151 | Q6UXH8 | |
| CSAYYERCLQLLRPG | 191 | Q86VU5 | |
| YRIGRCPNTYACCLR | 46 | Q8WTQ1 | |
| YPSREVAICLDPYCG | 1171 | Q9Y2E4 | |
| RRNYVCSFPGCRKTY | 391 | O14901 | |
| CRRTCYYPTTVCLPG | 116 | Q9BYQ4 | |
| CRRTCYYPTTVCLPG | 101 | Q9BYQ2 | |
| CRPICSGLLTYRQPY | 401 | A8MUX0 | |
| YRPCYSILRRPACVT | 426 | A8MUX0 | |
| PACVTSYSCRPVYFR | 436 | A8MUX0 | |
| SYSCRPVYFRPSCTE | 441 | A8MUX0 | |
| CRRTCYYPTTVCLPG | 96 | Q9BYP9 | |
| IRLPYFRDNVCLTYC | 301 | Q5VU92 | |
| ECPQGYYLSEDTRIC | 1676 | P35556 | |
| GYRCVDTNRCVEPYI | 306 | O95967 | |
| GYYSCRVSRSSLKPC | 86 | Q92826 | |
| RAYDPSSRCYRGCVL | 2366 | Q9UGM3 | |
| TVCQLIEGTRYPACR | 106 | Q5GAN4 | |
| CRAGTYYDGARERCI | 641 | Q9NQ36 | |
| LGLVCEIGLRCRTYY | 1291 | A3KN83 | |
| EIGLRCRTYYVLCGS | 1296 | A3KN83 | |
| PVGVNTECYRIYEAC | 331 | Q9Y2B1 | |
| YYCRVRGGRCAVLSC | 31 | P81534 | |
| DCREEQYPCTRLYSI | 96 | P55001 | |
| CITAAPYRGISCYRG | 31 | P78385 | |
| ICPYCNREFTYIGSL | 1456 | Q13029 | |
| CTKGGPIYIITEYCR | 671 | P09619 | |
| QYGCCSLVYLRPRSS | 256 | Q8NGQ4 | |
| LGPYVRCLVGSVLYC | 231 | Q9Y6J9 | |
| DGPRTRCPVYIYSCS | 1231 | Q5T011 | |
| RCPVYIYSCSLEALR | 1236 | Q5T011 | |
| VLYTDCIRQCSGPLY | 671 | Q8NBJ9 | |
| YICRAVICRCTTYDG | 486 | O75159 | |
| VVDCTCFGLPRRYII | 51 | Q9P2U7 | |
| LVYISCCLAGRAYPL | 726 | Q8N3P4 | |
| DRYVAICSPLLYSTC | 121 | Q8WZ94 | |
| VGTRYKCSVCPDYDL | 136 | Q13501 | |
| YEYEPPCTSLCARVQ | 416 | Q96AP0 | |
| PVIVYRCVDYITQCG | 971 | Q96P48 | |
| VYCLRTPRGLEMYDC | 126 | A6NFN9 | |
| YSCCPRLASVLLYSD | 141 | Q13057 | |
| DCTCFGLPRRYIIAI | 61 | Q9P2U8 | |
| AGLRPYSCERCGKAY | 191 | Q96K58 | |
| CPTCRRETVLFTDYG | 186 | Q9H0X6 | |
| TCPYCDRGYKRFTSL | 171 | P37275 | |
| VFSCPACRYDLGRSY | 756 | Q96T88 | |
| GYRFCSPCQRYVSLE | 376 | Q9H5U6 | |
| RVYPCRYCTEGKRTF | 1021 | Q8N1G0 | |
| PVYCLCRLPYDVTRF | 41 | Q9UPP1 | |
| ARPYVCSECGKAYIS | 556 | Q9HCX3 | |
| ILGYCRGEAVYSRDC | 666 | Q01831 | |
| LTCPYCDRGYKRLTS | 211 | O60315 | |
| PYKCGECRRAFYRSS | 261 | Q9UEG4 | |
| GYRQLCGCYLTRDDV | 396 | Q9NVH6 | |
| SPYQRRDSDRYCGLC | 136 | Q9H898 | |
| CITAAPYRGISCYRG | 26 | Q14533 | |
| TYGPFCAERLRRTYA | 1161 | Q6PIF6 |